Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micropoint Technologies is a Singapore-based medical technology company focused on microneedle solutions for transdermal drug delivery and in-vitro diagnostics. Founded in 2008 as a spin-off from Singapore's Institute of Materials Research & Engineering, the company develops and manufactures microneedle-based products including patches, hollow microneedle hubs, and microneedle templates. Its business appears to center on platform technology, prototyping, product development, OEM manufacturing, and pilot-scale production rather than a disclosed therapeutic drug pipeline. The company states that it is cGMP compliant and ISO 13485 certified, and that its pilot facility can produce clinical batches of dissolving microneedle patches for clinical trials. Micropoint therefore fits best as an active medtech and drug-delivery platform company serving healthcare, diagnostics, and partner development needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micropoint Technologies.